CN1593528A - Dispersible tablet for treating urination difficulty and its preparation method - Google Patents
Dispersible tablet for treating urination difficulty and its preparation method Download PDFInfo
- Publication number
- CN1593528A CN1593528A CN 200410023393 CN200410023393A CN1593528A CN 1593528 A CN1593528 A CN 1593528A CN 200410023393 CN200410023393 CN 200410023393 CN 200410023393 A CN200410023393 A CN 200410023393A CN 1593528 A CN1593528 A CN 1593528A
- Authority
- CN
- China
- Prior art keywords
- dispersible tablet
- radix
- preparation
- qianlielongbitong
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Disclosed is a traditional Chinese medicament for treating prostate hyperplasia which mainly comprises (by weight portion) Radix Astragali, poria cocos wolf each 9-27%, wood louse, cluster mallow fruit, cassia twig, fruit of citron each 3-9%, peach kernel 4-11%, epimeddium, giant knotweed rhizome, cyathula root each 5-14%, radix bupleuri 2-6%. Its preparing process is also disclosed in the invention.
Description
Technical field:
The present invention relates to a kind of dispersible tablets of Chinese medicine and preparation technology's method thereof, relate in particular to 'Qianlielongbitong ' dispersible tablet and preparation method thereof.
Background technology:
Dispersible tablet is a kind of novel medicament dosage form, according to the relevant laws and regulations of China's drug control, changes dosage form and manages as new drug research.The original dosage form of this product is a capsule, has listed the national drug standards in.
The technology features of former dosage form be with prescription Chinese crude drug water carry, concentrate, drying, pulverizing, encapsulated, promptly.
There is difficult disintegrate in existing 'Qianlielongbitong ' capsule, and onset is slow, the drawback of medicine stability difference.
Summary of the invention:
The purpose of this invention is to provide the rapid disintegrate onset of a kind of energy, be used for the treatment of Chinese patent medicine preparation of prostatic hyperplasia and preparation method thereof, overcome the above-mentioned drawback of prior art, improve the quality and the curative effect of product, satisfy the needs of medical treatment better.
Technical solution of the present invention is a kind of 'Qianlielongbitong ' dispersible tablet, be a kind of Chinese patent medicine that is used for the treatment of prostatic hyperplasia, it is characterized in that it is that main constituent is the dispersible tablet of the Radix Astragali, Eupolyphaga Seu Steleophaga, Fructus Malvae, Semen Persicae, Ramulus Cinnamomi, Herba Epimedii, Radix Bupleuri, Poria, Rhizoma Polygoni Cuspidati, Fructus Aurantii, Radix Cyathulae.
A kind of preparation method of 'Qianlielongbitong ' dispersible tablet is characterized in that:
(1) getting main medicine constituent and percentage by weight thereof is:
The Radix Astragali, Poria each 9～27%, Eupolyphaga Seu Steleophaga, Fructus Malvae, Ramulus Cinnamomi, Fructus Aurantii each 3～9%, Semen Persicae 4～11%, Herba Epimedii, Rhizoma Polygoni Cuspidati, Radix Cyathulae each 5～14%, Radix Bupleuri 2～6%;
(2) get said medicine and add the decocting digestion 1～3 time, each amount of water is 6～14 times of amounts of medication amount, and each 1～3 hour, medicinal liquid merged, and filtered; The best is: add the decocting digestion 3 times, and the 1st time 3 hours, the 2nd, 3 time each 2 hours;
(3) medicinal liquid with above-mentioned (2) gained is concentrated into thick paste;
(4) with the thick paste of above-mentioned (3) gained, drying under reduced pressure, dried cream powder were broken into 80～160 purpose fine powders, and best superfine powder was broken into 200～300 purpose fine powders, and was standby.
(5) with the fine powder and the appropriate amount of auxiliary materials of above-mentioned (4) gained, mixing is made dispersible tablet, and packing promptly.
(6) used adjuvant can be in the preparation method: any/multiple mixing during micropowder silica gel, starch, dextrin, magnesium stearate, essence, Pulvis Talci, sucrose, microcrystalline Cellulose, carboxymethyl starch are received is used.
Specific embodiments:
The present invention further specifies as follows in conjunction with specific embodiments:
A kind of 'Qianlielongbitong ' dispersible tablet is a kind of Chinese patent medicine for the treatment of prostatic hyperplasia, and it contains main constituent and is: the Radix Astragali, Eupolyphaga Seu Steleophaga, Fructus Malvae, Semen Persicae, Ramulus Cinnamomi, Herba Epimedii, Radix Bupleuri, Poria, Rhizoma Polygoni Cuspidati, Fructus Aurantii, Radix Cyathulae.It has the QI invigorating warming YANG, and the activating blood and promoting diuresis function is used for the treatment of the difficulty in urination due to the blood stasis due to renal deficiency, and disease is seen frequent micturition, urinate in delaying, require great effort, and dribble of urine, soreness of the waist and knees, prostatic hyperplasia are seen above-mentioned patient.
A kind of optimum implementation of 'Qianlielongbitong ' dispersible tablet preparation method is:
(1) getting main medicine constituent and optimum weight percentage ratio thereof is: the Radix Astragali, Poria each 18.4%, Eupolyphaga Seu Steleophaga, Fructus Malvae, Ramulus Cinnamomi, Fructus Aurantii each 6.1%, Semen Persicae 7.4%, Herba Epimedii, Rhizoma Polygoni Cuspidati, Radix Cyathulae each 9.2%, Radix Bupleuri 3.7%;
(2) above medicine adds the decocting digestion three times, and 3 hours for the first time, second and third time each 2 hours, collecting decoction filters, and filtrate is concentrated into thick paste, drying, dried cream powder is broken into fine powder, adds appropriate amount of auxiliary materials, and mixing is made dispersible tablet, and packing is promptly.
Advantage of the present invention is; After taking, dispersible tablet for treating urination difficulty gets final product rapid disintegration, and rapid-action, medicine stability Good, be beneficial to storage, produce, carry and improve the product curative effect, can satisfy better the treatment needs.
Claims (3)
1, a kind of 'Qianlielongbitong ' dispersible tablet, be a kind of Chinese patent medicine for the treatment of prostatic hyperplasia, it is characterized in that it is that main constituent is the dispersible tablet of the Radix Astragali, Eupolyphaga Seu Steleophaga, Fructus Malvae, Semen Persicae, Ramulus Cinnamomi, Herba Epimedii, Radix Bupleuri, Poria, Rhizoma Polygoni Cuspidati, Fructus Aurantii, Radix Cyathulae.
2, a kind of preparation method of 'Qianlielongbitong ' dispersible tablet is characterized in that:
(1) getting main medicine constituent and percentage by weight thereof is:
The Radix Astragali, Poria each 9～27%, Eupolyphaga Seu Steleophaga, Fructus Malvae, Ramulus Cinnamomi, Fructus Aurantii each 3～9%, Semen Persicae 4～11%, Herba Epimedii, Rhizoma Polygoni Cuspidati, Radix Cyathulae each 5～14%, Radix Bupleuri 2～6%;
(2) get said medicine and decoct with water 1～3 time, each amount of water is 6～14 times of amounts of medication amount, each 1～3 hour; The best is: decoct with water 3 times, the 1st time 3 hours, the 2nd, 3 time each 2 hours, amount of water was 8～10 times of medication amount; Medicinal liquid merges, and filters;
(3) medicinal liquid with above-mentioned (2) gained is concentrated into thick paste;
(4) with the thick paste of above-mentioned (3) gained, drying under reduced pressure, dried cream powder were broken into 80～160 purpose fine powders, and best superfine powder was broken into 200～300 purpose fine powders, and was standby.
(5) with the fine powder and the appropriate amount of auxiliary materials of above-mentioned (4) gained, mixing is made dispersible tablet, and packing promptly.
3, the preparation method of 'Qianlielongbitong ' dispersible tablet according to claim 2 is characterized in that the optimum weight percentage ratio of its main constituent is:
The Radix Astragali, Poria each 18.4%, Eupolyphaga Seu Steleophaga, Fructus Malvae, Ramulus Cinnamomi, Fructus Aurantii each 6.1%, Semen Persicae 7.4%, Herba Epimedii, Rhizoma Polygoni Cuspidati, Radix Cyathulae each 9.2%, Radix Bupleuri 3.7%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410023393 CN1593528A (en) | 2004-07-06 | 2004-07-06 | Dispersible tablet for treating urination difficulty and its preparation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410023393 CN1593528A (en) | 2004-07-06 | 2004-07-06 | Dispersible tablet for treating urination difficulty and its preparation method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1593528A true CN1593528A (en) | 2005-03-16 |
Family
ID=34663425
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200410023393 Pending CN1593528A (en) | 2004-07-06 | 2004-07-06 | Dispersible tablet for treating urination difficulty and its preparation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1593528A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1331494C (en) * | 2005-05-20 | 2007-08-15 | 王威 | Method for preparing Chinese medicinal tablet for treating prostate disease |
-
2004
- 2004-07-06 CN CN 200410023393 patent/CN1593528A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1331494C (en) * | 2005-05-20 | 2007-08-15 | 王威 | Method for preparing Chinese medicinal tablet for treating prostate disease |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101502588B (en) | Composition for beauty treatment and removing blain and method for preparing the same | |
| CN100569220C (en) | A kind of menstruation regulation and macula removal tablet that is used for gynecological and preparation method thereof | |
| CN1123347C (en) | Chinese medicine for decreasing fat and lossing weight and preparation method thereof | |
| CN105267559B (en) | A kind of drug and preparation method thereof for treating diabete peripheral herve pathology | |
| CN1839981A (en) | Gynecological inflammation resisting dispersion tablet and its preparation method | |
| CN101664504B (en) | Medicament for treating diabetes and preparation method thereof | |
| CN1698854A (en) | Tablet for treating urination difficulty caused by prostate hyperplasia and its preparation process | |
| CN102114189A (en) | Chinese medicinal blood glucose reducing tablet for treating diabetes comprising superfine powder | |
| CN1456206A (en) | Qi-blood tonifying capsule | |
| CN101549075B (en) | Traditional Chinese medicine composition for treating mammary gland hyperplasia and preparation method thereof | |
| CN101167951A (en) | Traditional Chinese medicinal composition for treating diabetes and its preparation method | |
| CN1593528A (en) | Dispersible tablet for treating urination difficulty and its preparation method | |
| CN101987188B (en) | Biological Chinese patent drug for preventing and treating hyperlipoidemia | |
| CN101461877B (en) | Medicament composition for recovery of physical strength for women | |
| CN1292272A (en) | Medicine for curing diabetes and its preparation method | |
| CN1593603A (en) | Emmeniopathy treating Chinese medicinal capsule and its preparation | |
| CN1593532A (en) | Prostatitis treating capsule and its preparing method | |
| CN1593604A (en) | Dispersible tablet for treating mammary glands hyperplasia and its preparing method | |
| CN103690834B (en) | A kind of blood pressure lowering Chinese medicinal composition and preparation method thereof | |
| CN1709359A (en) | Tablet for treating women's pelvic inflammation and its preparing method | |
| CN1600359A (en) | Capsule for curing high blood fat and preparation method | |
| CN100577195C (en) | Application of Chinese medicine composiiton in preparing medicine for treating salpingitis, oophoritic cyst, colpitis and cervicitis | |
| CN1759867A (en) | Granules of Chinese traditional medicine for treating women's irregular menses | |
| CN105213537A (en) | A kind of pharmaceutical composition for the treatment of congestive heart failure | |
| CN1596961A (en) | Chinese patent drug dispersing tablet for treating gynecologic inflammation and its preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |